碧桂園(02007.HK)將贖回未償還本金額5.5億美元2022年4月票據
格隆匯1月7日丨碧桂園(02007.HK)公佈,根據公司、附屬公司擔保人及花旗國際(作為受託人)就有關發行2022年4月票據所訂立日期為2019年1月25日的債券契約的條款(經不時修訂或補充),公司於今日宣佈,其已知會受託人及2022年4月票據持有人,所有尚未償還的2022年4月票據將於2021年2月5日(“贖回日期”)悉數贖回,贖回價相等於尚未償還2022年4月票據本金額的103.5625%,另加直至(但不包括)贖回日期的累計及未付利息。
於該公吿日期,2022年4月票據的未償還本金額為5.5億美元。於贖回尚未償還的2022年4月票據後,2022年4月票據將會註銷,並據此從新交所的上市名單中除牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.